Case Report: Disseminated Tuberculosis After Kidney Transplantation
- 4 September 2024
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 111 (3) , 535-539
Abstract
: Tuberculosis (TB) can cause significant morbidity and mortality among solid organ transplant (SOT) recipients, including disseminated disease. Most TB cases after SOT occur in kidney transplant recipients, although data about TB in this population are sparse. Tuberculosis may present atypically in immunocompromised patients, underscoring why physicians must maintain high clinical suspicion when pertinent epidemiological risk factors are present, including birth or former residence in a country with endemic TB. We describe a unique case of disseminated TB in a 54-year-old Filipino woman who developed central nervous system tuberculoma, Pott’s disease, chorioretinitis, and a perinephric fluid collection after kidney transplantation. Despite being a preventable and curable disease, TB remains a relevant and challenging infection with complex diagnostic and treatment guidelines.Keywords
This publication has 26 references indexed in Scilit:
- Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of TaiwanJournal of the Formosan Medical Association, 2023
- Whole-genome single nucleotide variant phylogenetic analysis of Mycobacterium tuberculosis Lineage 1 in endemic regions of Asia and AfricaScientific Reports, 2022
- Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysisMicrobial Pathogenesis, 2020
- Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance—United States, 2005-2016Journal of Public Health Management & Practice, 2019
- Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the PhilippinesScientific Reports, 2019
- Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of TransplantationClinical Transplantation, 2019
- Mycobacterium tuberculosisafter solid organ transplantation: A review of more than 2000 casesClinical Transplantation, 2018
- Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Expert Review of Clinical Pharmacology, 2017
- Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidatesInfection, 2017
- Short-Course Isoniazid Plus Rifapentine Directly Observed Therapy for Latent Tuberculosis in Solid-Organ Transplant CandidatesTransplantation, 2014